Cargando…

Prospective comparison of (18)F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer

PURPOSE: To prospectively compare (18)F-prostate-specific membrane antigen (PSMA)-1007 positron emission tomography (PET)/CT, whole-body magnetic resonance imaging (WBMRI) including diffusion-weighted imaging (DWI) and standard computed tomography (CT), in primary nodal staging of prostate cancer (P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malaspina, Simona, Anttinen, Mikael, Taimen, Pekka, Jambor, Ivan, Sandell, Minna, Rinta-Kiikka, Irina, Kajander, Sami, Schildt, Jukka, Saukko, Ekaterina, Noponen, Tommi, Saunavaara, Jani, Dean, Peter B., Sequeiros, Roberto Blanco, Aronen, Hannu J., Kemppainen, Jukka, Seppänen, Marko, Boström, Peter J., Ettala, Otto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263440/ https://www.ncbi.nlm.nih.gov/pubmed/33715033 http://dx.doi.org/10.1007/s00259-021-05296-1

Ejemplares similares

Comparison of standardized uptake values between (99m)Tc-HDP SPECT/CT and (18)F-NaF PET/CT in bone metastases of breast and prostate cancer
por: Arvola, Samuli, et al.
Publicado: (2019)

Flare on [(18)F]PSMA-1007 PET/CT after short-term androgen deprivation therapy and its correlation to FDG uptake: possible marker of tumor aggressiveness in treatment-naïve metastatic prostate cancer patients
por: Malaspina, Simona, et al.
Publicado: (2022)

Detection of prostate cancer bone metastases with fast whole-body (99m)Tc-HMDP SPECT/CT using a general-purpose CZT system
por: Arvola, Samuli, et al.
Publicado: (2022)

Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0)
por: Ettala, Otto, et al.
Publicado: (2022)

Prediction of prostate cancer aggressiveness using (18)F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI
por: Movahedi, Parisa, et al.
Publicado: (2020)

The Clinical Impact of Using (18)F-FDG-PET/CT in the Diagnosis of Suspected Vasculitis: The Effect of Dose and Timing of Glucocorticoid Treatment
por: Taimen, Kirsi, et al.
Publicado: (2019)

(11)C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial)
por: Salminen, Antti, et al.
Publicado: (2018)

Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT
por: Majala, Susanna, et al.
Publicado: (2019)

Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with (68)Ga-PSMA-11 PET/MRI in men with treatment-naïve prostate cancer
por: Ettala, Otto, et al.
Publicado: (2019)

Evolving imaging methods of prostate cancer and the emergence of magnetic resonance imaging guided ablation techniques
por: Anttinen, Mikael, et al.
Publicado: (2022)

Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer: 12-Month Functional and Oncological Results
por: Anttinen, Mikael, et al.
Publicado: (2020)

Correlation of Somatostatin Receptor 1–5 Expression, [(68)Ga]Ga-DOTANOC, [(18)F]F-FDG PET/CT and Clinical Outcome in a Prospective Cohort of Pancreatic Neuroendocrine Neoplasms
por: Majala, Susanna, et al.
Publicado: (2021)

Diagnostic Accuracy of (18)F-FDG-PET/CT and (18)F-FDG-PET/MRI in Detecting Locoregional Recurrence of HNSCC 12 Weeks after the End of Chemoradiotherapy: Single-Center Experience with PET/MRI
por: Murtojärvi, Sarita, et al.
Publicado: (2022)

Value of (68)Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [(18)F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study
por: Beheshti, Mohsen, et al.
Publicado: (2022)

How to read biparametric MRI in men with a clinical suspicious of prostate cancer: Pictorial review for beginners with public access to imaging, clinical and histopathological database
por: Jambor, Ivan, et al.
Publicado: (2021)

Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study
por: Laasik, Maren, et al.
Publicado: (2019)

Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial
por: Jambor, Ivan, et al.
Publicado: (2019)

Correlation between (18)F-1-amino-3-fluorocyclobutane-1-carboxylic acid ((18)F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer
por: Saarinen, Irena, et al.
Publicado: (2019)

Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma: Association with Metabolic Tumor Burden Determined with FDG-PET/CT
por: Silvoniemi, Antti, et al.
Publicado: (2023)

RADIATION DOSE OF THE EYE LENS IN CT EXAMINATIONS OF THE BRAIN IN CLINICAL PRACTICE—THE EFFECT OF RADIOGRAPHER TRAINING TO OPTIMISE GANTRY TILT AND SCAN LENGTH
por: Tarkiainen, Jeremias, et al.
Publicado: (2023)

Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study
por: Falagario, Ugo, et al.
Publicado: (2020)

PET-CT detection of local residual laryngeal carcinoma after definitive (chemo)radiotherapy
por: Sistonen, Heli J., et al.
Publicado: (2023)

Head-to-Head Comparison of (68)Ga-Citrate and (18)F-FDG PET/CT for Detection of Infectious Foci in Patients with Staphylococcus aureus Bacteraemia
por: Salomäki, Soile P., et al.
Publicado: (2017)

FDG-PET/CT in the Assessment of Treatment Response after Oncologic Treatment of Head and Neck Squamous Cell Carcinoma
por: Keski-Säntti, Harri, et al.
Publicado: (2014)

The feasibility of [(18)F]EF5-PET/CT to image hypoxia in ovarian tumors: a clinical study
por: Laasik, Maren, et al.
Publicado: (2020)

Non-prostate uptake on (18)F-PSMA-1007 PET/CT: a case of myeloma
por: Veerasuri, Sowmya, et al.
Publicado: (2020)

Diagnostic accuracy of [(18)F]PSMA-1007 PET/CT in biochemical recurrence of prostate cancer
por: Mingels, Clemens, et al.
Publicado: (2022)

Deep learning prediction of non-perfused volume without contrast agents during prostate ablation therapy
por: Wright, Cameron, et al.
Publicado: (2022)

Evolution of non-perfused volume after transurethral ultrasound ablation of prostate: A retrospective 12-month analysis
por: Mäkelä, Pietari, et al.
Publicado: (2023)

Bupropion Causes Misdiagnosis in Brain Dopamine Transporter Imaging for Parkinsonism
por: Honkanen, Emma A., et al.
Publicado: (2019)

Meta-analysis of (18) F-PSMA-1007 PET/CT, (18) F-FDG PET/CT, and (68)Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
por: Yu, Wenxiao, et al.
Publicado: (2023)

Classification of head and neck cancer from PET images using convolutional neural networks
por: Hellström, Henri, et al.
Publicado: (2023)

Diagnostic performance of (18)F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer
por: Rahbar, Kambiz, et al.
Publicado: (2018)

Optimization of [(18)F]PSMA-1007 PET-CT using regularized reconstruction in patients with prostate cancer
por: Trägårdh, Elin, et al.
Publicado: (2020)

Primary Staging of Prostate Cancer Patients with [(18)F]PSMA-1007 PET/CT Compared with [(68)Ga]Ga-PSMA-11 PET/CT
por: Hoffmann, Manuela A., et al.
Publicado: (2022)

MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study
por: Holli-Helenius, Kirsi, et al.
Publicado: (2017)

Radiomics and machine learning of multisequence multiparametric prostate MRI: Towards improved non-invasive prostate cancer characterization
por: Toivonen, Jussi, et al.
Publicado: (2019)

The value of (18)F-PSMA-1007 PET/CT in identifying non-metastatic high-risk prostate cancer
por: Hong, Jun-jie, et al.
Publicado: (2020)

Diagnostic Role of (18)F-PSMA-1007 PET/CT in Prostate Cancer Staging: A Systematic Review
por: Awenat, Salam, et al.
Publicado: (2021)

PSMA-Positive Low Malignant Gastrointestinal Stromal Tumor in the Stomach on F-18-PSMA-1007 PET/CT
por: Iversen, Peter, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0psd93ic85l56ev7hiph4hu34m